In-depth valuation analysis including DCF scenarios and peer comparisons.
AI Insight: UnitedHealth Group's current price exceeds its PERT-weighted fair value by 15.3%, indicating potential overvaluation amid a wide valuation range. High profitability contrasts with weak growth and liquidity scores, reflecting uneven financial health. Monte Carlo shows significant volatility and 66.7% downside risk, highlighting marked investment uncertainty.